98 related articles for article (PubMed ID: 2406045)
1. Nonlinearity of measurements of a tumor marker for breast cancer.
Cooper EH; Forbes MA; Laurence V; Beya MF; de Chastonay J
Clin Chem; 1990 Feb; 36(2):408-9. PubMed ID: 2406045
[No Abstract] [Full Text] [Related]
2. A comparison of CA-549 with CA 15-3 and MCA in patients with metastatic breast cancer.
de Wit R; Hoek FJ; Bakker PJ; Veenhof CH
Ann Oncol; 1992 Apr; 3(4):314-5. PubMed ID: 1390307
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.
Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H
Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273
[TBL] [Abstract][Full Text] [Related]
4. CA-15.3, TPA and MCA as markers for breast cancer.
Barak M; Steiner M; Finkel B; Abrahamson J; Antal S; Gruener N
Eur J Cancer; 1990; 26(5):577-80. PubMed ID: 2144745
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment concentrations of breast carcinoma antigen (CA 15.3) and mucin-like carcinoma-associated antigen in patients with carcinoma of the breast.
Góźdź SS; Kowalska MM; Słuszniak JT; Słuszniak A; Korejba W; Bukowski J; Banasińska E; al-Jazzaf H; Szymendera JJ
Tumour Biol; 1989; 10(2):103-8. PubMed ID: 2734547
[TBL] [Abstract][Full Text] [Related]
7. CA125 in ovarian tumour tissue at second laparotomy.
Maughan TS; Fish RG; Shelley MD; Jasani B; Williams GT; Adams M
Br J Cancer; 1989 Feb; 59(2):259-60. PubMed ID: 2649131
[No Abstract] [Full Text] [Related]
8. Elevated CA125 levels in patients with metastatic breast carcinoma.
Perey L; Hayes DF; Tondini C; van Melle G; Bauer J; Lemarchand T; Reymond M; Mach JP; Leyvraz S
Br J Cancer; 1990 Oct; 62(4):668-70. PubMed ID: 2223588
[No Abstract] [Full Text] [Related]
9. [Basic study of CA549, a new tumor marker for breast cancer, and evaluation of its clinical usefulness].
Yamaguchi A; Ushigome M; Imai T; Otake H; Igarashi H; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Mar; 30(3):317-22. PubMed ID: 8479100
[TBL] [Abstract][Full Text] [Related]
10. [CA 15-3--a tumor marker in breast cancer].
Cohen AD; Cohen Y; Shoenfeld Y
Harefuah; 1993 Dec; 125(12):484-7. PubMed ID: 8112686
[No Abstract] [Full Text] [Related]
11. Sweet beginning for cancer stem cells.
Baum LG
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):815-6. PubMed ID: 26772316
[No Abstract] [Full Text] [Related]
12. [The expression of NCC-ST-439, a tumor marker, in human breast cancer patients].
Miyahara E; Toi M; Wada T; Yamada H; Osaki A; Yanagawa E; Toge T
Gan No Rinsho; 1990 Sep; 36(11):2023-6. PubMed ID: 2232168
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate tumor marker: basis for a simple test for colorectal cancer.
Shamsuddin AM; Sakamoto K
Adv Exp Med Biol; 1994; 354():85-99. PubMed ID: 8067291
[No Abstract] [Full Text] [Related]
14. Serial serum MCA measurements in the follow-up of breast cancer patients.
Merimsky O; Inbar M; Hareuveni M; Witenberg B; Wolman Y; Chaitchik S
Eur J Cancer; 1991; 27(11):1440-4. PubMed ID: 1835861
[TBL] [Abstract][Full Text] [Related]
15. [Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines].
Kausitz J
Bratisl Lek Listy; 1988 Aug; 89(8):563-76. PubMed ID: 3179762
[No Abstract] [Full Text] [Related]
16. Follow-up of metastatic breast cancer patients with a mucin-like carcinoma-associated antigen: comparison to CA 15.3 and carcinoembryonic antigen.
Bieglmayer C; Szepesi T; Neunteufel W
Cancer Lett; 1988 Nov; 42(3):199-206. PubMed ID: 2461250
[TBL] [Abstract][Full Text] [Related]
17. STn and prognosis in breast cancer.
Leivonen M; Nordling S; Lundin J; von Boguslawski K; Haglund C
Oncology; 2001; 61(4):299-305. PubMed ID: 11721177
[TBL] [Abstract][Full Text] [Related]
18. [CA 15-3 in breast cancer].
Zito GA; Callipari S; Capuano S; Tommasielli G; Pignatelli F; Varricchio M
Boll Soc Ital Biol Sper; 1988 Jul; 64(7):663-6. PubMed ID: 3228512
[No Abstract] [Full Text] [Related]
19. CA-125 is not a useful marker in metastatic breast cancer.
Seckl MJ; Rustin GJ; Coombes RC
Br J Cancer; 1992 Nov; 66(5):875-6. PubMed ID: 1419631
[No Abstract] [Full Text] [Related]
20. Occurrence of a human tumor marker (Ca 72-4) in animal seminal plasma.
Uhlenbruck G; Dietz E; Schmid DO; Haeger O
Naturwissenschaften; 1988 Jul; 75(7):359-60. PubMed ID: 3211208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
